TOP PICK
Humana Inc

They serve 17 million benefits plan members, focusing on Medicare, the fastest-growing segment in US healthcare. Boasts 20% return on shareholder equity, growing earnings at 14% compounded over the past decade. This should continue, given demographics and inflation. Also, in a non-cyclical part of the market in coming quarters. Pullback allows a good entry point.

(Analysts’ price target is $597.91)
medical services
COMMENT
Humana Inc
They reported today. Their quarter was good--not as bad as the street thought--but UnitedHealth's and Centene's reports were even better. UNH is best in terms of technology. He prefers these two.
medical services
PAST TOP PICK
Humana Inc
(A Top Pick Oct 28/19, Up 41%) He trimmed it but still owns it. He likes their focus on the Medicare segment of the healthcare space. A lot of the headline risk has gone following the election. There is a huge tailwind of new customers for them as people turn 65 in the US. There is still huge growth opportunity over the next few years.
medical services
PAST TOP PICK
Humana Inc
(A Top Pick Sep 03/19, Up 45%) He bought it 18 months ago, when there were worries about Democratic candidates who may pressure U.S. medical insurance. The Medicare advantage is a serious tailwind given aging demographics in coming years--a lot of people will buy this insurance and Humana sits in the sweet spot. There'll be volatility in this space before the November vote, but medical insurance will remain a force. He sold some shares, but still likes this stock and sees a good long term.
medical services
TOP PICK
Humana Inc
It is in a very interesting part of the insurance space in the US, focusing on Medicare. 10,000 people a day in the US are turning 65. The demographic tailwind is going to be huge. This is part of the healthcare market he really likes. (Analysts’ price target is $327.14)
medical services
TOP PICK
Humana Inc
There's great opportunity in U.S. health insurers. But Pressure from politicians ahead of the 2020 election are pressuring drug and health stocks. He doesn't believe the State will go to nationalized healthcare, as the Democrats want. Humana is a Medicare Advantage provider; over 70% of revenue comes from here, and Americans are aging--demographics favour Humana. (Analysts’ price target is $334.86)
medical services
BUY on WEAKNESS
Humana Inc

Closed at $182.52 and his model price is only $129, so it is trading 30% over what it should be valued at. He would be interested in this at $156.

medical services
TOP PICK
Humana Inc
Likes the Health Management Sector.
medical services
Showing 1 to 8 of 8 entries
  • «
  • 1
  • »

Humana Inc(HUM-N) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Humana Inc is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Humana Inc(HUM-N) Frequently Asked Questions

What is Humana Inc stock symbol?

Humana Inc is a American stock, trading under the symbol HUM-N on the New York Stock Exchange (HUM). It is usually referred to as NYSE:HUM or HUM-N

Is Humana Inc a buy or a sell?

In the last year, there was no coverage of Humana Inc published on Stockchase.

Is Humana Inc a good investment or a top pick?

Humana Inc was recommended as a Top Pick by on . Read the latest stock experts ratings for Humana Inc.

Why is Humana Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Humana Inc worth watching?

0 stock analysts on Stockchase covered Humana Inc In the last year. It is a trending stock that is worth watching.

What is Humana Inc stock price?

On 2023-02-23, Humana Inc (HUM-N) stock closed at a price of $510.65.